Legal & General Group’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.48M Sell
181,359
-4,200
-2% -$34.2K ﹤0.01% 2093
2025
Q1
$1.46M Buy
185,559
+36,352
+24% +$285K ﹤0.01% 2041
2024
Q4
$2.22M Buy
149,207
+2,233
+2% +$33.2K ﹤0.01% 1935
2024
Q3
$2.25M Sell
146,974
-1,857
-1% -$28.4K ﹤0.01% 1917
2024
Q2
$2.27M Sell
148,831
-1,421
-0.9% -$21.6K ﹤0.01% 1886
2024
Q1
$2.84M Buy
150,252
+1,322
+0.9% +$25K ﹤0.01% 1778
2023
Q4
$2.84M Sell
148,930
-1,265
-0.8% -$24.2K ﹤0.01% 1778
2023
Q3
$2.7M Buy
150,195
+5,140
+4% +$92.3K ﹤0.01% 1760
2023
Q2
$2.95M Sell
145,055
-3,785
-3% -$76.9K ﹤0.01% 1734
2023
Q1
$2.71M Sell
148,840
-1,735
-1% -$31.6K ﹤0.01% 1738
2022
Q4
$3.11M Buy
150,575
+2,024
+1% +$41.9K ﹤0.01% 1667
2022
Q3
$3.89M Buy
148,551
+11,335
+8% +$297K ﹤0.01% 1493
2022
Q2
$3.48M Buy
137,216
+100,107
+270% +$2.54M ﹤0.01% 1599
2022
Q1
$1.17M Buy
37,109
+19,227
+108% +$607K ﹤0.01% 2191
2021
Q4
$723K Sell
17,882
-482
-3% -$19.5K ﹤0.01% 2315
2021
Q3
$640K Buy
18,364
+8,095
+79% +$282K ﹤0.01% 2354
2021
Q2
$281K Sell
10,269
-1,237
-11% -$33.8K ﹤0.01% 2458
2021
Q1
$323K Buy
11,506
+445
+4% +$12.5K ﹤0.01% 2372
2020
Q4
$287K Sell
11,061
-80
-0.7% -$2.08K ﹤0.01% 2355
2020
Q3
$191K Sell
11,141
-320
-3% -$5.49K ﹤0.01% 2366
2020
Q2
$284K Buy
11,461
+6,476
+130% +$160K ﹤0.01% 2287
2020
Q1
$69K Sell
4,985
-1,685
-25% -$23.3K ﹤0.01% 2510
2019
Q4
$68K Hold
6,670
﹤0.01% 2711
2019
Q3
$61K Buy
6,670
+852
+15% +$7.79K ﹤0.01% 2669
2019
Q2
$47K Hold
5,818
﹤0.01% 2801
2019
Q1
$73K Hold
5,818
﹤0.01% 2591
2018
Q4
$62K Buy
5,818
+4,404
+311% +$46.9K ﹤0.01% 2614
2018
Q3
$20K Buy
1,414
+651
+85% +$9.21K ﹤0.01% 3207
2018
Q2
$9K Buy
+763
New +$9K ﹤0.01% 3310